BEAM

Beam Therapeutics Inc.

Contracts

Total Value

Stock Metrics

26.7%

Short % Float

11.3d to cover · High squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

FMR, LLC

Top Holder

12.2% of float

88.0M sh

Public Float

15/100

Dilution Score

Low

33 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

15/100

LOW

Inst: 1.08% · Top: FMR, LLC

Biotech Analytics

Base Editing

43.79

Squeeze risk: HIGHBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk15

Clinical Trials75

Short Interest70